Healthcare, Industrials Jul 06, 2021 06:49 PM (GMT+8) · EqualOcean
Wantai bio announced that its wholly-owned subsidiary Wantai Carey plans to invest in the construction and implementation of "Xiamen Wantai diagnosis base construction project", with an estimated total investment of 1.336 billion yuan. On the same day announcement, the New Coronavirus (2019-nCoV) antigen detection kit (colloidal gold method) produced by the company was approved by the national drug and Health Products Safety Administration (ANSM) recently and can be sold in the French market.
Related companies: